PubMed:7629157
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-133 | Sentence | denotes | Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. |
| T2 | 134-328 | Sentence | denotes | Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear. |
| T3 | 329-463 | Sentence | denotes | In the present study, the role of serine/threonine phosphatases in the regulation of I kappa B alpha phosphorylation was investigated. |
| T4 | 464-768 | Sentence | denotes | Our studies demonstrate that incubation of human T cells with low concentrations (approximately 1-5 nM) of calyculin A or okadaic acid, potent inhibitors of protein phosphatase type 1 (PP-1) and type 2A (PP-2A), induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus. |
| T5 | 769-1021 | Sentence | denotes | This action of the phosphatase inhibitors, which is associated with the activation of the RelA.p50 NF-kappa B heterodimer, is not affected by agents that block the induction of I kappa B alpha phosphorylation by tumor necrosis factor alpha (TNF-alpha). |
| T6 | 1022-1323 | Sentence | denotes | Furthermore, the phosphorylated I kappa B alpha from calyculin A-treated cells, but not that from TNF-alpha-stimulated cells, is sensitive to PP-2A in vitro, suggesting the existence of fundamental differences in the phosphorylation of I kappa B alpha induced by the two different NF-kappa B inducers. |
| T7 | 1324-1492 | Sentence | denotes | However, induction of I kappa B alpha phosphorylation by both TNF-alpha and the phosphatase inhibitors is associated with the subsequent degradation of I kappa B alpha. |
| T8 | 1493-1659 | Sentence | denotes | We further demonstrate that TNF-alpha- and calyculin A-induced I kappa B alpha degradation exhibits similar but not identical sensitivities to a proteasome inhibitor. |
| T9 | 1660-1883 | Sentence | denotes | Together, these results suggest that phosphorylation of I kappa B alpha, mediated through both the TNF-alpha-inducible and the PP-2A-opposing kinases, may serve to target I kappa B alpha for proteasome-mediated degradation. |
| T1 | 0-133 | Sentence | denotes | Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. |
| T2 | 134-328 | Sentence | denotes | Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear. |
| T3 | 329-463 | Sentence | denotes | In the present study, the role of serine/threonine phosphatases in the regulation of I kappa B alpha phosphorylation was investigated. |
| T4 | 464-768 | Sentence | denotes | Our studies demonstrate that incubation of human T cells with low concentrations (approximately 1-5 nM) of calyculin A or okadaic acid, potent inhibitors of protein phosphatase type 1 (PP-1) and type 2A (PP-2A), induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus. |
| T5 | 769-1021 | Sentence | denotes | This action of the phosphatase inhibitors, which is associated with the activation of the RelA.p50 NF-kappa B heterodimer, is not affected by agents that block the induction of I kappa B alpha phosphorylation by tumor necrosis factor alpha (TNF-alpha). |
| T6 | 1022-1323 | Sentence | denotes | Furthermore, the phosphorylated I kappa B alpha from calyculin A-treated cells, but not that from TNF-alpha-stimulated cells, is sensitive to PP-2A in vitro, suggesting the existence of fundamental differences in the phosphorylation of I kappa B alpha induced by the two different NF-kappa B inducers. |
| T7 | 1324-1492 | Sentence | denotes | However, induction of I kappa B alpha phosphorylation by both TNF-alpha and the phosphatase inhibitors is associated with the subsequent degradation of I kappa B alpha. |
| T8 | 1493-1659 | Sentence | denotes | We further demonstrate that TNF-alpha- and calyculin A-induced I kappa B alpha degradation exhibits similar but not identical sensitivities to a proteasome inhibitor. |
| T9 | 1660-1883 | Sentence | denotes | Together, these results suggest that phosphorylation of I kappa B alpha, mediated through both the TNF-alpha-inducible and the PP-2A-opposing kinases, may serve to target I kappa B alpha for proteasome-mediated degradation. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-24 | protein | denotes | NF-kappa B |
| T2 | 28-39 | protein | denotes | phosphatase |
| T3 | 83-98 | protein | denotes | I kappa B alpha |
| T4 | 102-132 | protein | denotes | phosphatase 2A-sensitive sites |
| T5 | 148-158 | protein | denotes | NF-kappa B |
| T6 | 261-276 | protein | denotes | I kappa B alpha |
| T7 | 363-392 | protein | denotes | serine/threonine phosphatases |
| T8 | 414-429 | protein | denotes | I kappa B alpha |
| T9 | 507-520 | cell_type | denotes | human T cells |
| T10 | 621-666 | protein | denotes | protein phosphatase type 1 (PP-1) and type 2A |
| T11 | 668-673 | protein | denotes | PP-2A |
| T12 | 707-722 | protein | denotes | I kappa B alpha |
| T13 | 859-890 | protein | denotes | RelA.p50 NF-kappa B heterodimer |
| T14 | 946-961 | protein | denotes | I kappa B alpha |
| T15 | 981-1008 | protein | denotes | tumor necrosis factor alpha |
| T16 | 1010-1019 | protein | denotes | TNF-alpha |
| T17 | 1039-1069 | protein | denotes | phosphorylated I kappa B alpha |
| T18 | 1075-1100 | cell_line | denotes | calyculin A-treated cells |
| T19 | 1120-1146 | cell_line | denotes | TNF-alpha-stimulated cells |
| T20 | 1164-1169 | protein | denotes | PP-2A |
| T21 | 1258-1273 | protein | denotes | I kappa B alpha |
| T22 | 1303-1313 | protein | denotes | NF-kappa B |
| T23 | 1346-1361 | protein | denotes | I kappa B alpha |
| T24 | 1386-1395 | protein | denotes | TNF-alpha |
| T25 | 1476-1491 | protein | denotes | I kappa B alpha |
| T26 | 1716-1731 | protein | denotes | I kappa B alpha |
| T27 | 1759-1768 | protein | denotes | TNF-alpha |
| T28 | 1787-1809 | protein | denotes | PP-2A-opposing kinases |
| T29 | 1831-1846 | protein | denotes | I kappa B alpha |
| T30 | 1851-1861 | protein | denotes | proteasome |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-133 | Sentence | denotes | Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. |
| S2 | 134-328 | Sentence | denotes | Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear. |
| S3 | 329-463 | Sentence | denotes | In the present study, the role of serine/threonine phosphatases in the regulation of I kappa B alpha phosphorylation was investigated. |
| S4 | 464-768 | Sentence | denotes | Our studies demonstrate that incubation of human T cells with low concentrations (approximately 1-5 nM) of calyculin A or okadaic acid, potent inhibitors of protein phosphatase type 1 (PP-1) and type 2A (PP-2A), induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus. |
| S5 | 769-1021 | Sentence | denotes | This action of the phosphatase inhibitors, which is associated with the activation of the RelA.p50 NF-kappa B heterodimer, is not affected by agents that block the induction of I kappa B alpha phosphorylation by tumor necrosis factor alpha (TNF-alpha). |
| S6 | 1022-1323 | Sentence | denotes | Furthermore, the phosphorylated I kappa B alpha from calyculin A-treated cells, but not that from TNF-alpha-stimulated cells, is sensitive to PP-2A in vitro, suggesting the existence of fundamental differences in the phosphorylation of I kappa B alpha induced by the two different NF-kappa B inducers. |
| S7 | 1324-1492 | Sentence | denotes | However, induction of I kappa B alpha phosphorylation by both TNF-alpha and the phosphatase inhibitors is associated with the subsequent degradation of I kappa B alpha. |
| S8 | 1493-1659 | Sentence | denotes | We further demonstrate that TNF-alpha- and calyculin A-induced I kappa B alpha degradation exhibits similar but not identical sensitivities to a proteasome inhibitor. |
| S9 | 1660-1883 | Sentence | denotes | Together, these results suggest that phosphorylation of I kappa B alpha, mediated through both the TNF-alpha-inducible and the PP-2A-opposing kinases, may serve to target I kappa B alpha for proteasome-mediated degradation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 14-24 | NP | denotes | NF-kappa B |
| C2 | 28-50 | NP | denotes | phosphatase inhibitors |
| C4 | 83-98 | NP | denotes | I kappa B alpha |
| C3 | 60-98 | NP | denotes | the phosphorylation of I kappa B alpha |
| C5 | 148-158 | NP | denotes | NF-kappa B |
| C7 | 246-249 | NP | denotes | its |
| C6 | 246-259 | NP | denotes | its inhibitor |
| C8 | 261-276 | NP | denotes | I kappa B alpha |
| C9 | 414-445 | NP | denotes | I kappa B alpha phosphorylation |
| C10 | 571-598 | NP | denotes | calyculin A or okadaic acid |
| C11 | 600-674 | NP | denotes | potent inhibitors of protein phosphatase type 1 (PP-1) and type 2A (PP-2A) |
| C13 | 707-722 | NP | denotes | I kappa B alpha |
| C12 | 684-722 | NP | denotes | the phosphorylation of I kappa B alpha |
| C15 | 784-810 | NP | denotes | the phosphatase inhibitors |
| C14 | 769-810 | NP | denotes | This action of the phosphatase inhibitors |
| C16 | 812-817 | NP | denotes | which |
| C17 | 911-917 | NP | denotes | agents |
| C18 | 918-922 | NP | denotes | that |
| C19 | 946-977 | NP | denotes | I kappa B alpha phosphorylation |
| C20 | 981-1020 | NP | denotes | tumor necrosis factor alpha (TNF-alpha) |
| C21 | 1035-1069 | NP | denotes | the phosphorylated I kappa B alpha |
| C22 | 1110-1114 | NP | denotes | that |
| C24 | 1258-1273 | NP | denotes | I kappa B alpha |
| C23 | 1235-1273 | NP | denotes | the phosphorylation of I kappa B alpha |
| C25 | 1346-1377 | NP | denotes | I kappa B alpha phosphorylation |
| C26 | 1386-1395 | NP | denotes | TNF-alpha |
| C27 | 1400-1426 | NP | denotes | the phosphatase inhibitors |
| C28 | 1476-1491 | NP | denotes | I kappa B alpha |
| C30 | 1716-1731 | NP | denotes | I kappa B alpha |
| C29 | 1697-1731 | NP | denotes | phosphorylation of I kappa B alpha |
| C31 | 1831-1846 | NP | denotes | I kappa B alpha |
| R1 | C5 | C1 | coref-ident | NF-kappa B,NF-kappa B |
| R2 | C7 | C5 | coref-pron | its,NF-kappa B |
| R3 | C6 | C4 | coref-ident | its inhibitor,I kappa B alpha |
| R4 | C8 | C6 | coref-appos | I kappa B alpha,its inhibitor |
| R5 | C9 | C3 | coref-ident | I kappa B alpha phosphorylation,the phosphorylation of I kappa B alpha |
| R6 | C11 | C10 | coref-appos | potent inhibitors of protein phosphatase type 1 (PP-1) and type 2A (PP-2A),calyculin A or okadaic acid |
| R7 | C13 | C8 | coref-ident | I kappa B alpha,I kappa B alpha |
| R8 | C12 | C9 | coref-ident | the phosphorylation of I kappa B alpha,I kappa B alpha phosphorylation |
| R9 | C15 | C2 | coref-ident | the phosphatase inhibitors,phosphatase inhibitors |
| R10 | C16 | C14 | coref-relat | which,This action of the phosphatase inhibitors |
| R11 | C18 | C17 | coref-relat | that,agents |
| R12 | C19 | C12 | coref-ident | I kappa B alpha phosphorylation,the phosphorylation of I kappa B alpha |
| R13 | C22 | C21 | coref-pron | that,the phosphorylated I kappa B alpha |
| R14 | C24 | C13 | coref-ident | I kappa B alpha,I kappa B alpha |
| R15 | C23 | C19 | coref-ident | the phosphorylation of I kappa B alpha,I kappa B alpha phosphorylation |
| R16 | C25 | C23 | coref-ident | I kappa B alpha phosphorylation,the phosphorylation of I kappa B alpha |
| R17 | C26 | C20 | coref-ident | TNF-alpha,tumor necrosis factor alpha (TNF-alpha) |
| R18 | C27 | C15 | coref-ident | the phosphatase inhibitors,the phosphatase inhibitors |
| R19 | C28 | C24 | coref-ident | I kappa B alpha,I kappa B alpha |
| R20 | C30 | C28 | coref-ident | I kappa B alpha,I kappa B alpha |
| R21 | C29 | C25 | coref-ident | phosphorylation of I kappa B alpha,I kappa B alpha phosphorylation |
| R22 | C31 | C30 | coref-ident | I kappa B alpha,I kappa B alpha |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-24 | protein_molecule | denotes | NF-kappa B |
| T2 | 28-39 | protein_family_or_group | denotes | phosphatase |
| T3 | 64-79 | other_name | denotes | phosphorylation |
| T4 | 83-98 | protein_molecule | denotes | I kappa B alpha |
| T5 | 102-132 | protein_domain_or_region | denotes | phosphatase 2A-sensitive sites |
| T6 | 148-158 | protein_molecule | denotes | NF-kappa B |
| T7 | 170-186 | other_name | denotes | cellular stimuli |
| T8 | 200-215 | other_name | denotes | phosphorylation |
| T9 | 250-260 | other_name | denotes | inhibitor, |
| T10 | 261-276 | protein_molecule | denotes | I kappa B alpha |
| T11 | 363-392 | protein_molecule | denotes | serine/threonine phosphatases |
| T12 | 414-429 | protein_molecule | denotes | I kappa B alpha |
| T13 | 507-520 | cell_type | denotes | human T cells |
| T14 | 571-582 | other_organic_compound | denotes | calyculin A |
| T15 | 586-598 | other_organic_compound | denotes | okadaic acid |
| T16 | 668-673 | protein_family_or_group | denotes | PP-2A |
| T17 | 688-703 | other_name | denotes | phosphorylation |
| T18 | 707-722 | protein_molecule | denotes | I kappa B alpha |
| T19 | 788-810 | other_organic_compound | denotes | phosphatase inhibitors |
| T20 | 859-867 | protein_complex | denotes | RelA.p50 |
| T21 | 868-878 | protein_molecule | denotes | NF-kappa B |
| T22 | 946-961 | protein_molecule | denotes | I kappa B alpha |
| T23 | 981-1008 | protein_molecule | denotes | tumor necrosis factor alpha |
| T24 | 1010-1019 | protein_molecule | denotes | TNF-alpha |
| T25 | 1039-1053 | protein_molecule | denotes | phosphorylated |
| T26 | 1054-1069 | protein_molecule | denotes | I kappa B alpha |
| T27 | 1075-1086 | other_organic_compound | denotes | calyculin A |
| T28 | 1120-1129 | protein_molecule | denotes | TNF-alpha |
| T29 | 1164-1169 | protein_family_or_group | denotes | PP-2A |
| T30 | 1239-1254 | other_name | denotes | phosphorylation |
| T31 | 1258-1273 | protein_molecule | denotes | I kappa B alpha |
| T32 | 1303-1313 | protein_molecule | denotes | NF-kappa B |
| T33 | 1346-1361 | protein_molecule | denotes | I kappa B alpha |
| T34 | 1386-1395 | protein_molecule | denotes | TNF-alpha |
| T35 | 1404-1426 | other_organic_compound | denotes | phosphatase inhibitors |
| T36 | 1476-1491 | protein_molecule | denotes | I kappa B alpha |
| T37 | 1638-1658 | other_organic_compound | denotes | proteasome inhibitor |
| T38 | 1697-1712 | other_name | denotes | phosphorylation |
| T39 | 1716-1731 | protein_molecule | denotes | I kappa B alpha |
| T40 | 1759-1768 | protein_molecule | denotes | TNF-alpha |
| T41 | 1787-1792 | protein_family_or_group | denotes | PP-2A |
| T42 | 1831-1846 | protein_molecule | denotes | I kappa B alpha |
| T43 | 1851-1861 | protein_complex | denotes | proteasome |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 981-986 | Phenotype | denotes | tumor | HP:0002664 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 981-986 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 507-512 | OrganismTaxon | denotes | human | 9606 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 513-520 | Cell | denotes | T cells | http://purl.obolibrary.org/obo/CL:0000084 |